Category: PSA Screening

The PSA screening debate was growing stale. Here are a few landmarks over nearly 50 years: Early 1970s – Richard Ablin, MD and others identify prostate specific antigen (PSA) as a biomarker for disease or disturbance in the prostate. 1987 – Thomas Stamey, MD notes that PSA is useful to monitor PCa patients for changes keep reading

The New York Times, like all news media, is a vehicle to air conflicting views. The November 25, 2014 issue ran a strongly-worded editorial opinion piece by Richard Ablin, PhD, the self-proclaimed “discoverer of PSA”... keep reading